Skip to main content

MICROVISION, INC.

For the period ended Dec 31, 2024. Filed Mar 26, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 26, 2025

MVIS$1.15-7.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 15. Exhibits, Financial Statement Schedules

(A) Documents filed as part of this Annual Report on Form 10-K:

1. Consolidated Financial Statements

●Report of Independent Registered Public Accounting Firm
●Consolidated Balance Sheets as of December 31, 2024 and 2023
●Consolidated Statements of Operations for the years ended December 31, 2024, 2023 and 2022
●Consolidated Statements of Comprehensive Loss for the years ended December 31, 2024, 2023 and 2022
●Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2024, 2023 and 2022
●Consolidated Statements of Cash Flows for the years ended December 31, 2024, 2023 and 2022
●Notes to Consolidated Financial Statements

2. Financial Statement Schedules

Schedule II

MicroVision, Inc.

Valuation and Qualifying Accounts and Reserves Schedule

Additions
Year Ended December 31, · Balance at beginning of fiscal period · Charges to costs and expenses · Charges to other accounts · Deductions · Balance at end of fiscal period
Tax valuation allowance$124,380$5,745$-$-$130,125
Tax valuation allowance$130,125$12,252$-$-$142,377
Tax valuation allowance$142,37710,558$-$-$152,935

All other schedules are omitted because they are not applicable, or because the information required is included in the consolidated financial statements and notes thereto.

3. Exhibits

The following exhibits are referenced or included in this Annual Report on Form 10-K.

Exhibit NumberDescription
2.1Asset Purchase Agreement, dated December 1, 2022, by and between Ibeo Automotive Systems GmbH and MicroVision GmbH(14)
2.2Amendment Agreement, dated January 31, 2023, to the Asset Purchase Agreement, dated December 1, 2022, by and between Ibeo Automotive Systems GmbH and MicroVision GmbH(14)
3.1Amended and Restated Certificate of Incorporation of MicroVision, Inc., as amended(2)
3.2Certificate of Amendment to the Amended and Restated Certificate of Incorporation of MicroVision, Inc(4)
3.3Certificate of Amendment to the Amended and Restated Certificate of Incorporation of MicroVision, Inc. dated June 7, 2018(6)
3.4Certificate of Amendment to the Amended and Restated Certificate of Incorporation of MicroVision, Inc. dated October 8, 2020(8)
3.5Certificate of Amendment to the Amended and Restated Certificate of Incorporation of MicroVision, Inc. dated May, 18, 2023(7)
3.6Amended and Restated Bylaws of MicroVision, Inc(5)
4.1Form of Specimen Stock Certificate for Common Stock(1)
4.2Description of Common Stock(9)
4.3Form of Senior Secured Convertible Note(19)
10.12022 MicroVision, Inc. Incentive Plan(13)*
10.2Lease Agreement Concerning Office Premises between Victoria Immo Properties I S.à r.l., dated December 15, 2023 (covering approximately 60,000 square feet)(20)
10.3Key Executive Severance and Change in Control Plan(3)*
10.4Employment Agreement between MicroVision, Inc. and Sumit Sharma dated April 8, 2021(11)
10.5At-the-Market Issuance Sales Agreement, dated August 29, 2023, by and between the Company and Craig-Hallum Capital Group LLC(10)
10.6Lease Agreement between Redmond East Office Park LLC and MicroVision, Inc. dated September 24, 2021 (covering approximately 16,681 square feet)(12)
10.7Lease Agreement between Redmond East Office Park LLC and MicroVision, Inc. dated September 24, 2021 (covering approximately 36,062 square feet)(12)
10.8Form of Performance-Based Restricted Stock Unit Agreement(13)*
10.9Form of Restricted Stock Unit Agreement(15)*
10.10At-the-Market Issuance Sales Agreement, dated June 16,2023, by and between the Company and Craig-Hallum Capital Group LLC(16)
10.112024 Executive Bonus Plan(3)
10.12At-the-Market Issuance Sales Agreement, dated March 5, 2024, by and among the Company and various banks(17)
10.132024 CEO Agreement(18)*
10.14Securities Purchase Agreement(19)
19.1MicroVision Statement of Policy on Insider Trading and Pre-Clearance Procedures
21.1List of Subsidiaries of the Registrant
23.1Consent of Independent Registered Public Accounting Firm – Moss Adams LLP
31.1Principal Executive Officer Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2Principal Financial Officer Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1Principal Executive Officer Certification pursuant to Rule 13a-14(b) or Rule 15d-14(b) and Section 1350, Chapter 63 of Title 18, United States Code (18 U.S.C. 1350), as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002
32.2Principal Financial Officer Certification pursuant to Rule 13a-14(b) or Rule 15d-14(b) and Section 1350, Chapter 63 of Title 18, United States Code (18 U.S.C. 1350), as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002
97.1Policy on Recoupment of Incentive Compensation
101.INSInline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCHInline XBRL Taxonomy Extension Schema
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
(1)Incorporated by reference to the Company’s Post-Effective Amendment to Form S-3 Registration Statement, Registration No. 333-102244.
(2)Incorporated by reference to the Company’s Form 10-Q for the quarterly period ended September 30, 2009.
(3)Incorporated by reference to the Company’s Form 10-Q for the quarterly period ended June 30, 2024.
(4)Incorporated by reference to the Company’s Current Report on Form 8-K filed on February 17, 2012.
(5)Incorporated by reference to the Company’s Current Report on Form 8-K filed on July 14, 2023.
(6)Incorporated by reference to the Company’s Amendment No. 2 to Form S-1 Registration Statement, Registration No. 333-222857.
(7)Incorporated by reference to the Company’s Current Report on Form 8-K filed on May 19, 2023.
(8)Incorporated by reference to the Company’s Form 10-Q for the quarterly period ended September 30, 2020.
(10)Incorporated by reference to the Company’s Current Report on Form 8-K filed on August 29, 2023.
(11)Incorporated by reference to the Company’s Form 10-Q for the quarterly period ended June 30, 2021.
(12)Incorporated by reference to the Company’s Form 10-Q for the quarterly period ended September 30, 2021.
(13)Incorporated by reference to the Company’s Form S-8 filed on June 8, 2022.
(14)Incorporated by reference to the Company’s Current Report on Form 8-K filed on February 3, 2023.
(16)Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 16, 2023.
(17)Incorporated by reference to the Company’s Current Report on Form 8-K filed on March 5, 2025.
(18)Incorporated by reference to the Company’s Form 10-Q for the quarterly period ended September 30, 2024.
(19)Incorporated by reference to the Company’s Current Report on Form 8-K filed on October 15, 2024.
*Management contracts and compensatory plans and arrangements required to be filed as exhibits pursuant to Item 15(b) of this Annual Report on Form 10-K.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.